XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Commitment to Issue Class A Common Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Related Party Notes Payable
The9 Conditional Obligation
Cumulative Effect, Period of Adoption, Adjustment
Class A Common Stock
Class A Common Stock
Related Party Notes Payable
Class A Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
The9 Conditional Obligation
Common Stock
Class B Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Related Party Notes Payable
Additional Paid-in Capital
The9 Conditional Obligation
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020               93,099,596   64,000,588            
Beginning balance at Dec. 31, 2020 $ (579,338)             $ 9   $ 6 $ 1,817,760     $ (5,974) $ (2,391,139)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of convertible securities (in shares)           10,888,580     423,053              
Conversion of convertible securities   $ 134,359 $ 2,863     $ 1           $ 134,358 $ 2,863      
Stock-based compensation 3,468                   3,468          
Exercise of stock options (in shares)               3,248,425                
Exercise of stock options 7,752                   7,752          
Issuance of warrants 7,113                   7,113          
Foreign currency translation adjustment (676)                         (676)    
Net loss (128,300)                           (128,300)  
Ending balance (in shares) at Jun. 30, 2021               107,659,654   64,000,588            
Ending balance at Jun. 30, 2021 (552,759)             $ 10   $ 6 1,973,314     (6,650) (2,519,439)  
Beginning balance (in shares) at Mar. 31, 2021               94,777,273   64,000,588            
Beginning balance at Mar. 31, 2021 (644,334)             $ 9   $ 6 1,827,781     (5,466) (2,466,664)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of convertible securities (in shares)           10,888,580                    
Conversion of convertible securities   $ 134,359       $ 1           $ 134,358        
Stock-based compensation 948                   948          
Exercise of stock options (in shares)               1,993,801                
Exercise of stock options 5,102                   5,102          
Issuance of warrants 5,125                   5,125          
Foreign currency translation adjustment (1,184)                         (1,184)    
Net loss (52,775)                           (52,775)  
Ending balance (in shares) at Jun. 30, 2021               107,659,654   64,000,588            
Ending balance at Jun. 30, 2021 (552,759)             $ 10   $ 6 1,973,314     (6,650) (2,519,439)  
Beginning balance (in shares) at Dec. 31, 2021         0                      
Beginning balance at Dec. 31, 2021         $ 0                      
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021             $ 32,900                  
Ending balance (in shares) at Jun. 30, 2022         0                      
Ending balance at Jun. 30, 2022         $ 32,900                      
Beginning balance (in shares) at Dec. 31, 2021               168,693,323   0            
Beginning balance at Dec. 31, 2021 567,654             $ 17   $ 0 3,482,226     (6,945) (2,907,644)  
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021       $ (20,265)                       $ (20,265)
Beginning balance (Accounting Standards Update 2016-02) at Dec. 31, 2021       $ 3,393                       $ 3,393
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of shares pursuant to the commitment to issue Class A and Class B Common Stock (Note 3) (in shares)               68,887,416   64,000,588            
Issuance of shares pursuant to the commitment to issue Class A and Class B Common Stock (Note 3) 0             $ 7   $ 6 (13)          
Stock-based compensation 6,474                   6,474          
Exercise of stock options (in shares)               962,736                
Exercise of stock options 2,354                   2,354          
Foreign currency translation adjustment 3,684                         3,684    
Net loss (294,792)                           (294,792)  
Ending balance (in shares) at Jun. 30, 2022               238,543,475   64,000,588            
Ending balance at Jun. 30, 2022 268,502             $ 24   $ 6 3,491,041     (3,261) (3,219,308)  
Beginning balance (in shares) at Mar. 31, 2022         0                      
Beginning balance at Mar. 31, 2022         $ 32,900                      
Ending balance (in shares) at Jun. 30, 2022         0                      
Ending balance at Jun. 30, 2022         $ 32,900                      
Beginning balance (in shares) at Mar. 31, 2022               238,197,018   64,000,588            
Beginning balance at Mar. 31, 2022 402,322             $ 24   $ 6 3,487,415     (7,509) (3,077,614)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of shares pursuant to the commitment to issue Class A and Class B Common Stock (Note 3) (in shares)               145,396                
Stock-based compensation 3,127                   3,127          
Exercise of stock options (in shares)               201,061                
Exercise of stock options 499                   499          
Foreign currency translation adjustment 4,248                         4,248    
Net loss (141,694)                           (141,694)  
Ending balance (in shares) at Jun. 30, 2022               238,543,475   64,000,588            
Ending balance at Jun. 30, 2022 $ 268,502             $ 24   $ 6 $ 3,491,041     $ (3,261) $ (3,219,308)